Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Meet the 10 Fastest Growing Companies Paving the Path to Success in 2023 Business
  • YNB Healthcare Introduces World Class Medical Equipments to offer 24*7 Emergency Healthcare Solutions at Home Business
  • 40 Under 40 Industry Leaders 2024: Celebrating the Leaders Shaping Our Future Business
  • AMRITAM GAMAYA – The International Festival of Music and Dance by the Ministry of Culture and  Kalakshetra Foundation Press Release
  • Don’t Suffer in Silence: Expert Fistula & Pilonidal Sinus Treatment in Malappuram Press Release
  • Bollywood Actor and Director Arbaaz Khan tie up with Fashion Brand Rohini Sethi Haute Couture for an exclusive Photoshoot Business
  • Harish Jagtani Foundation successfully launched the free dialysis coverage campaign Press Release
  • Vidya Scholarship Program – Bridging The Gap Between Dreams And Reality Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Renowned Dental Implant Expert, Dr. Aroon K. Bengani(Jain), Invites Patients Worldwide to Experience Immediate Loading Implants at Simpladent Surat Health
  • Compassionate Crusader: India’s leading therapist Dr. Amaya Sharma Revolutionizes Mental Health Advocacy with Empathy and Excellence Health
  • Acclaimed Developmental Paediatrician Dr. Samir Dalwai Inaugurates Latest New Horizons Centre in Mahim Health
  • Thrissur Piles Clinic Wins Award for Minimally Invasive Treatments Health
  • Universal Sompo & SOMPO CARE Align with Skill India Mission for cross-border health and wellbeing Health
  • Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India Health

Recent Posts

  • How Translite Scaffolding Ltd. Approaches Complex Infrastructure Execution in High-Traffic Airport Environments
  • Abhishek Rungta: India’s GCCs Are at Their Most Critical Inflection Point in 25 Years. Here Is What Must Change
  • Addressing India’s Employability Challenge: How Tata IIS Is Creating Industry-Ready Talent for the Future
  • 10 Best CEOs in India 2026 Officially Announced By TradeFlock Magazine
  • TradeFlock Announces India’s 10 Most Influential Healthcare Leaders 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Surat’s Alliance Group to Honour Olympic Star Gold Medalist Neeraj Chopra Press Release
  • Helmet Distribution Campaign for Delivery Partners by Vega X AOB X Possibilitea Lifestyle
  • CKOSMIC Health City: Long-Term Support for Weight Loss Health
  • Key Difference Between Best Health Insurance and Basic Health Insurance Policy Lifestyle
  • KP Group is moving fast in the solar sector, receiving another large order of 12.50 MW CPP Business
  • Cost Savings and Efficiency Gains: The Financial Benefits of Cloud-Based Construction ERP Technology
  • Annual Event to Commemorate Civilian-Led Peacebuilding in Mindanao Calls Forth Collective Action to Develop Peace Press Release
  • Patil Automation Strengthens North India Presence by Commissioning Faridabad Facility Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme